Zobrazeno 1 - 2
of 2
pro vyhledávání: '"David Albandea‐Rodríguez"'
Autor:
Pilar Bustamante-Madrid, Antonio Barbáchano, David Albandea-Rodríguez, Javier Rodríguez-Cobos, Nuria Rodríguez-Salas, Isabel Prieto, Aurora Burgos, Jaime Martínez de Villarreal, Francisco X. Real, José Manuel González-Sancho, María Jesús Larriba, Miguel Lafarga, Alberto Muñoz, Asunción Fernández-Barral
Publikováno v:
Cell Death and Disease, Vol 15, Iss 4, Pp 1-16 (2024)
Abstract Understanding the mechanisms involved in colonic epithelial differentiation is key to unraveling the alterations causing inflammatory conditions and cancer. Organoid cultures provide an unique tool to address these questions but studies are
Externí odkaz:
https://doaj.org/article/1747eea4e0c942f3bab2ba3f194d57d3
Autor:
Raquel Pascual-Serra, Diego M. Fernández-Aroca, Elena Arconada-Luque, Marta Ortega-Muelas, Ismael Muñoz, Ricardo Sánchez-Prieto, Borja Belandia, Olga Roche, Isabel Sánchez-Pérez, María José Ruiz-Hidalgo, José Antonio Encinar, David Albandea‐Rodríguez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Cellular and Molecular Medicine
instname
Journal of Cellular and Molecular Medicine
© 2021 The Authors.
Sorafenib is a multikinase inhibitor widely used in cancer therapy with an antitumour effect related to biological processes as proliferation, migration or invasion, among others. Initially designed as a Raf inhibitor, Soraf
Sorafenib is a multikinase inhibitor widely used in cancer therapy with an antitumour effect related to biological processes as proliferation, migration or invasion, among others. Initially designed as a Raf inhibitor, Soraf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e75248a9af458ee13eae2f9c9c29e7a
http://hdl.handle.net/10261/265002
http://hdl.handle.net/10261/265002
